Hikma Seeks To Meet Demand For 503B Compounding In US

CEO Sets Out Strategy For Company’s New Sterile Injectable Compounding Unit

 
• By David Wallace
  
Compounding bar chart growth green
Hikma expects a “gradual ramp-up” of the compounding business • Source: M-SUR / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business